Literature DB >> 20356838

Mouse Dfa is a repressor of TATA-box promoters and interacts with the Abt1 activator of basal transcription.

Christopher S Brower1, Lucia Veiga, Richard H Jones, Alexander Varshavsky.   

Abstract

Our study of the mouse Ate1 arginyltransferase, a component of the N-end rule pathway, has shown that Ate1 pre-mRNA is produced from a bidirectional promoter that also expresses, in the opposite direction, a previously uncharacterized gene (Hu, R. G., Brower, C. S., Wang, H., Davydov, I. V., Sheng, J., Zhou, J., Kwon, Y. T., and Varshavsky, A. (2006) J. Biol. Chem. 281, 32559-32573). In this work, we began analyzing this gene, termed Dfa (divergent from Ate1). Mouse Dfa was found to be transcribed from both the bidirectional P(Ate1/Dfa) promoter and other nearby promoters. The resulting transcripts are alternatively spliced, yielding a complex set of Dfa mRNAs that are present largely, although not exclusively, in the testis. A specific Dfa mRNA encodes, via its 3'-terminal exon, a 217-residue protein termed Dfa(A). Other Dfa mRNAs also contain this exon. Dfa(A) is sequelogous (similar in sequence) to a region of the human/mouse HTEX4 protein, whose physiological function is unknown. We produced an affinity-purified antibody to recombinant mouse Dfa(A) that detected a 35-kDa protein in the mouse testis and in several cell lines. Experiments in which RNA interference was used to down-regulate Dfa indicated that the 35-kDa protein was indeed Dfa(A). Furthermore, Dfa(A) was present in the interchromatin granule clusters and was also found to bind to the Ggnbp1 gametogenetin-binding protein-1 and to the Abt1 activator of basal transcription that interacts with the TATA-binding protein. Given these results, RNA interference was used to probe the influence of Dfa levels in luciferase reporter assays. We found that Dfa(A) acts as a repressor of TATA-box transcriptional promoters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356838      PMCID: PMC2878062          DOI: 10.1074/jbc.M110.118638

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Transcriptional analysis of the 69-kb sequence centromeric to HLA-J: a dense and complex structure of five genes.

Authors:  O Coriton; M Lepourcelet; A Hampe; F Galibert; J Mosser
Journal:  Mamm Genome       Date:  2000-12       Impact factor: 2.957

2.  Bidirectional gene organization: a common architectural feature of the human genome.

Authors:  Noritaka Adachi; Michael R Lieber
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

3.  An essential role of N-terminal arginylation in cardiovascular development.

Authors:  Yong Tae Kwon; Anna S Kashina; Ilia V Davydov; Rong-Gui Hu; Jee Young An; Jai Wha Seo; Fangyong Du; Alexander Varshavsky
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

Review 4.  Nuclear speckles: a model for nuclear organelles.

Authors:  Angus I Lamond; David L Spector
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

5.  A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd.

Authors:  Alexander I Agoulnik; Baisong Lu; Qichao Zhu; Cavatina Truong; Maria T Ty; Nelson Arango; Kiran K Chada; Colin E Bishop
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

6.  A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth.

Authors:  T Oda; K Kayukawa; H Hagiwara; H T Yudate; Y Masuho; Y Murakami; T A Tamura; M A Muramatsu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

7.  N-terminal acetylation of cellular proteins creates specific degradation signals.

Authors:  Cheol-Sang Hwang; Anna Shemorry; Alexander Varshavsky
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

8.  Mouse GGN1 and GGN3, two germ cell-specific proteins from the single gene Ggn, interact with mouse POG and play a role in spermatogenesis.

Authors:  Baisong Lu; Colin E Bishop
Journal:  J Biol Chem       Date:  2003-02-05       Impact factor: 5.157

9.  Identification of a novel gene linked to parkin via a bi-directional promoter.

Authors:  Andrew B West; Paul J Lockhart; Casey O'Farell; Matthew J Farrer
Journal:  J Mol Biol       Date:  2003-02-07       Impact factor: 5.469

10.  An abundance of bidirectional promoters in the human genome.

Authors:  Nathan D Trinklein; Shelley Force Aldred; Sara J Hartman; Diane I Schroeder; Robert P Otillar; Richard M Myers
Journal:  Genome Res       Date:  2004-01       Impact factor: 9.043

View more
  5 in total

1.  Liat1, an arginyltransferase-binding protein whose evolution among primates involved changes in the numbers of its 10-residue repeats.

Authors:  Christopher S Brower; Connor E Rosen; Richard H Jones; Brandon C Wadas; Konstantin I Piatkov; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

2.  Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene.

Authors:  Seongman Kim; Gan Dai; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virus Res       Date:  2012-01-14       Impact factor: 3.303

Review 3.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

4.  TMT-based quantitative proteomics analysis reveals the attenuated replication mechanism of Newcastle disease virus caused by nuclear localization signal mutation in viral matrix protein.

Authors:  Zhiqiang Duan; Chao Yuan; Yifan Han; Lei Zhou; Jiafu Zhao; Yong Ruan; Jiaqi Chen; Mengmeng Ni; Xinqin Ji
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

5.  ATE1-Mediated Post-Translational Arginylation Is an Essential Regulator of Eukaryotic Cellular Homeostasis.

Authors:  Verna Van; Aaron T Smith
Journal:  ACS Chem Biol       Date:  2020-11-23       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.